speb/financial-data huggingface dataset:
CELL.V balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 5125879.00
CELL.V income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 221187.00
CELL.V balance_sheet (quarterly, 2025-09-30) — Gross PPE: 3135551.00
CELL.V income_statement (quarterly, 2025-09-30) — Gross Profit: -2659.00
CELL.V income_statement (quarterly, 2025-09-30) — Insurance And Claims: 11949.00
CELL.V income_statement (quarterly, 2025-09-30) — Interest Income: 2631.00
CELL.V income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 2631.00
CELL.V balance_sheet (quarterly, 2025-09-30) — Invested Capital: 4107645.00
CELL.V cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -58181.00
CELL.V cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 0.00
CELL.V cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -3000.00
CELL.V cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
CELL.V income_statement (quarterly, 2025-09-30) — Net Income: -314400.00
CELL.V income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -314400.00
CELL.V income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -314400.00
CELL.V income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -314400.00
CELL.V income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -314400.00
CELL.V cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -314400.00
CELL.V income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -314400.00
CELL.V income_statement (quarterly, 2025-09-30) — Net Interest Income: 2213.00
CELL.V cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 0.00
CELL.V cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -3000.00
CELL.V cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -3000.00
CELL.V income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 2213.00
CELL.V cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: -58181.00
CELL.V balance_sheet (quarterly, 2025-09-30) — Net PPE: 3135551.00
CELL.V balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 4107645.00
CELL.V income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -317738.00
CELL.V income_statement (quarterly, 2025-09-30) — Normalized Income: -316292.00
CELL.V cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -249650.00
CELL.V income_statement (quarterly, 2025-09-30) — Operating Income: -318505.00
CELL.V income_statement (quarterly, 2025-09-30) — Operating Revenue: 0.00
CELL.V balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 193380795.00
CELL.V income_statement (quarterly, 2025-09-30) — Other Gand A: 209238.00
CELL.V income_statement (quarterly, 2025-09-30) — Other Income Expense: 1892.00
CELL.V cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 59.00
CELL.V income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 59.00
CELL.V balance_sheet (quarterly, 2025-09-30) — Other Properties: 3135551.00
CELL.V balance_sheet (quarterly, 2025-09-30) — Payables: 20604.00
CELL.V balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 40604.00
CELL.V balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 142321.00
CELL.V income_statement (quarterly, 2025-09-30) — Pretax Income: -314400.00
CELL.V cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 0.00
CELL.V balance_sheet (quarterly, 2025-09-30) — Receivables: 8721.00
CELL.V income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 2659.00
CELL.V income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 2659.00
CELL.V cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -3000.00
CELL.V balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -16408038.00
CELL.V cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 0.00
CELL.V income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 94600.00
CELL.V income_statement (quarterly, 2025-09-30) — Selling General And Administration: 315787.00
CELL.V balance_sheet (quarterly, 2025-09-30) — Share Issued: 193380795.00
CELL.V balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 4107645.00
CELL.V balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 4107645.00
CELL.V income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
CELL.V income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
CELL.V balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 8721.00
CELL.V balance_sheet (quarterly, 2025-09-30) — Total Assets: 4149242.00
CELL.V balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 4107645.00
CELL.V balance_sheet (quarterly, 2025-09-30) — Total Debt: 994.00
CELL.V balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 4107645.00
CELL.V income_statement (quarterly, 2025-09-30) — Total Expenses: 318505.00
CELL.V balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 41597.00
CELL.V balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 3135551.00
CELL.V balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: -1.00
CELL.V income_statement (quarterly, 2025-09-30) — Total Other Finance Cost: 418.00
CELL.V income_statement (quarterly, 2025-09-30) — Total Unusual Items: 1892.00
CELL.V income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 1892.00
CELL.V cash_flow (quarterly, 2025-09-30) — Unrealized Gain Loss On Investment Securities: 0.00
CELL.V balance_sheet (quarterly, 2025-09-30) — Working Capital: 972094.00
CELL.V income_statement (quarterly, 2025-12-31) — +Operating Expense: 250305.00
CELL.V income_statement (quarterly, 2025-12-31) — +Total Revenue: 0.00
CELL.V balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 25009.00
CELL.V income_statement (quarterly, 2025-12-31) — Basic Average Shares: 190380795.00
CELL.V income_statement (quarterly, 2025-12-31) — Basic EPS: 0.00
CELL.V cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 862649.00
CELL.V balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 0.00
CELL.V balance_sheet (quarterly, 2025-12-31) — Capital Stock: 15389804.00
CELL.V balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 541838.00
CELL.V balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 541838.00
CELL.V balance_sheet (quarterly, 2025-12-31) — Cash Financial: 541838.00
CELL.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -994.00
CELL.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -55442.00
CELL.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -264374.00
CELL.V cash_flow (quarterly, 2025-12-31) — Change In Payable: -15595.00
CELL.V cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -15595.00
CELL.V cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 10438.00
CELL.V cash_flow (quarterly, 2025-12-31) — Change In Receivables: -7085.00
CELL.V cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -12242.00
CELL.V cash_flow (quarterly, 2025-12-31) — Changes In Cash: -320811.00
CELL.V balance_sheet (quarterly, 2025-12-31) — Common Stock: 15389804.00
CELL.V balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 3854275.00
CELL.V cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 0.00
CELL.V income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 892.00
CELL.V balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 0.00
CELL.V balance_sheet (quarterly, 2025-12-31) — Current Assets: 689527.00
CELL.V balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 0.00
CELL.V balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 25009.00
CELL.V cash_flow (quarterly, 2025-12-31) — Depreciation: 892.00
CELL.V cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 892.00
CELL.V cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 892.00
CELL.V income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 190380795.00
CELL.V income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.00
CELL.V income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -253024.00
CELL.V income_statement (quarterly, 2025-12-31) — EBIT: -251197.00
CELL.V income_statement (quarterly, 2025-12-31) — EBITDA: -250305.00
CELL.V cash_flow (quarterly, 2025-12-31) — End Cash Position: 541838.00
CELL.V cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -994.00
CELL.V cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -264375.00
CELL.V income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: -1436.00
CELL.V balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 5125879.00
CELL.V income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 247505.00
CELL.V balance_sheet (quarterly, 2025-12-31) — Gross PPE: 3189757.00
CELL.V income_statement (quarterly, 2025-12-31) — Gross Profit: -892.00
CELL.V income_statement (quarterly, 2025-12-31) — Insurance And Claims: 15286.00
CELL.V income_statement (quarterly, 2025-12-31) — Interest Income: 0.00
CELL.V income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 0.00
CELL.V balance_sheet (quarterly, 2025-12-31) — Invested Capital: 3854275.00
CELL.V cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -55442.00
CELL.V cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 0.00
CELL.V cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -994.00
CELL.V cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
CELL.V income_statement (quarterly, 2025-12-31) — Net Income: -253024.00
CELL.V income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -253024.00
CELL.V income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -253024.00
CELL.V income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -253024.00
CELL.V income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -253024.00
CELL.V cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -253024.00
CELL.V income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -253024.00
CELL.V income_statement (quarterly, 2025-12-31) — Net Interest Income: -391.00
CELL.V cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 0.00
CELL.V cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -994.00
CELL.V cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -994.00
CELL.V income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -391.00
CELL.V cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: -55442.00
CELL.V balance_sheet (quarterly, 2025-12-31) — Net PPE: 3189757.00
CELL.V balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 3854275.00
CELL.V income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -248869.00
CELL.V income_statement (quarterly, 2025-12-31) — Normalized Income: -251588.00
CELL.V cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -264375.00
CELL.V income_statement (quarterly, 2025-12-31) — Operating Income: -251197.00
CELL.V income_statement (quarterly, 2025-12-31) — Operating Revenue: 0.00
CELL.V balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 193380795.00
CELL.V income_statement (quarterly, 2025-12-31) — Other Gand A: 230219.00
CELL.V income_statement (quarterly, 2025-12-31) — Other Income Expense: -1436.00
CELL.V cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -1.00
CELL.V balance_sheet (quarterly, 2025-12-31) — Other Properties: 3189757.00
CELL.V balance_sheet (quarterly, 2025-12-31) — Payables: 25009.00
CELL.V balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 25009.00
CELL.V balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 131883.00
CELL.V income_statement (quarterly, 2025-12-31) — Pretax Income: -253024.00
CELL.V cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 0.00
CELL.V balance_sheet (quarterly, 2025-12-31) — Receivables: 15806.00
CELL.V income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 892.00
CELL.V income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 892.00
CELL.V income_statement (quarterly, 2025-12-31) — Rent And Landing Fees: 2000.00
CELL.V income_statement (quarterly, 2025-12-31) — Rent Expense Supplemental: 2000.00
CELL.V cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -994.00
CELL.V balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -16661408.00
CELL.V cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 0.00
CELL.V income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 2800.00
CELL.V income_statement (quarterly, 2025-12-31) — Selling General And Administration: 250305.00
CELL.V balance_sheet (quarterly, 2025-12-31) — Share Issued: 193380795.00
CELL.V balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 3854275.00
CELL.V balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 3854275.00
CELL.V income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CELL.V income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
CELL.V balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 15806.00
CELL.V balance_sheet (quarterly, 2025-12-31) — Total Assets: 3879284.00
CELL.V balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 3854275.00
CELL.V balance_sheet (quarterly, 2025-12-31) — Total Debt: 0.00
CELL.V balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 3854275.00
CELL.V income_statement (quarterly, 2025-12-31) — Total Expenses: 251197.00
CELL.V balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 25009.00
CELL.V balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 3189757.00
CELL.V balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
CELL.V income_statement (quarterly, 2025-12-31) — Total Other Finance Cost: 391.00
CELL.V income_statement (quarterly, 2025-12-31) — Total Unusual Items: -1436.00
CELL.V income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -1436.00
CELL.V cash_flow (quarterly, 2025-12-31) — Unrealized Gain Loss On Investment Securities: 0.00
CELL.V balance_sheet (quarterly, 2025-12-31) — Working Capital: 664518.00
CELLO.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -1234090000.00
CELLO.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 10000.00
CELLO.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -55740000.00
CELLO.NS income_statement (annual, 2022-03-31) — Amortization: 1920000.00
CELLO.NS cash_flow (annual, 2022-03-31) — Amortization Cash Flow: 1920000.00
CELLO.NS balance_sheet (annual, 2022-03-31) — Assets Held For Sale Current: 0.00
CELLO.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 805230000.00
CELLO.NS balance_sheet (annual, 2022-03-31) — Cash Equivalents: 140010000.00
CELLO.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 222670000.00
CELLO.NS cash_flow (annual, 2022-03-31) — Common Stock Payments: 0.00
CELLO.NS balance_sheet (annual, 2022-03-31) — Defined Pension Benefit: 0.00
CELLO.NS balance_sheet (annual, 2022-03-31) — Dividends Payable: 5550000.00
CELLO.NS balance_sheet (annual, 2022-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 0.00
CELLO.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 2052940000.00
CELLO.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 79740000.00
CELLO.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 4122960000.00
CELLO.NS income_statement (annual, 2022-03-31) — Interest Income: 50640000.00
CELLO.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 50640000.00
CELLO.NS balance_sheet (annual, 2022-03-31) — Investmentsin Associatesat Cost: 0.00
CELLO.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 114820000.00
CELLO.NS balance_sheet (annual, 2022-03-31) — Long Term Debt: 0.00
CELLO.NS balance_sheet (annual, 2022-03-31) — Long Term Equity Investment: 0.00
CELLO.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 1921020000.00
CELLO.NS balance_sheet (annual, 2022-03-31) — Minority Interest: 1851340000.00
CELLO.NS income_statement (annual, 2022-03-31) — Minority Interests: -155220000.00
CELLO.NS balance_sheet (annual, 2022-03-31) — Net Debt: 4162080000.00
CELLO.NS cash_flow (annual, 2022-03-31) — Net Other Financing Charges: -210380000.00
CELLO.NS cash_flow (annual, 2022-03-31) — Net Preferred Stock Issuance: 0.00
CELLO.NS cash_flow (annual, 2022-03-31) — Net Short Term Debt Issuance: 3913710000.00
CELLO.NS balance_sheet (annual, 2022-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 45010000.00
CELLO.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 91180000.00
CELLO.NS balance_sheet (annual, 2022-03-31) — Other Inventories: 180820000.00
CELLO.NS balance_sheet (annual, 2022-03-31) — Other Payable: 4181910000.00
CELLO.NS income_statement (annual, 2022-03-31) — Other Special Charges: -800000.00
CELLO.NS balance_sheet (annual, 2022-03-31) — Preferred Securities Outside Stock Equity: 0.00
CELLO.NS cash_flow (annual, 2022-03-31) — Preferred Stock Issuance: 0.00
CELLO.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 349340000.00
CELLO.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
CELLO.NS cash_flow (annual, 2022-03-31) — Purchase Of Business: -1865500000.00
CELLO.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 1190640000.00
CELLO.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 170400000.00
CELLO.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 170400000.00
CELLO.NS cash_flow (annual, 2022-03-31) — Repurchase Of Capital Stock: 0.00
CELLO.NS income_statement (annual, 2022-03-31) — Research And Development: 3690000.00
CELLO.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 146200000.00
CELLO.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 4299410000.00
CELLO.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 671060000.00
CELLO.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 750800000.00
CELLO.NS cash_flow (annual, 2022-03-31) — Short Term Debt Issuance: 3913710000.00
CELLO.NS cash_flow (annual, 2022-03-31) — Short Term Debt Payments: -1184140000.00
CELLO.NS balance_sheet (annual, 2022-03-31) — Work In Process: 341050000.00
CELLO.NS income_statement (annual, 2022-03-31) — Write Off: 19180000.00
CELLO.NS income_statement (annual, 2023-03-31) — +Operating Expense: 4534788000.00
CELLO.NS income_statement (annual, 2023-03-31) — +Total Revenue: 17864814000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 1341672000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 4623031000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -1678259000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 1503000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -62523000.00
CELLO.NS income_statement (annual, 2023-03-31) — Amortization: 2638000.00
CELLO.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 2638000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Assets Held For Sale Current: 154440000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 456185000.00
CELLO.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 212231034.00
CELLO.NS income_statement (annual, 2023-03-31) — Basic EPS: 12.54
CELLO.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 362691000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 710151000.00
CELLO.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -1142536000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 90411000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 975000000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 306167000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 1622293000.00
CELLO.NS cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -96107000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Cash Equivalents: 0.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 306167000.00
CELLO.NS cash_flow (annual, 2023-03-31) — Change In Inventory: -532161000.00
CELLO.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: 5795000.00
CELLO.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: -50828000.00
CELLO.NS cash_flow (annual, 2023-03-31) — Change In Payable: 89369000.00
CELLO.NS cash_flow (annual, 2023-03-31) — Change In Receivables: -635510000.00
CELLO.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -1149731000.00
CELLO.NS cash_flow (annual, 2023-03-31) — Changes In Cash: -56524000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Common Stock: 975000000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 3364495000.00
CELLO.NS cash_flow (annual, 2023-03-31) — Common Stock Payments: -151189000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 606648000.00
CELLO.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 9469640000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Current Assets: 11398822000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 19060000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Current Debt: 3174042000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 3193102000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 5055008000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 14037000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Defined Pension Benefit: 0.00
CELLO.NS cash_flow (annual, 2023-03-31) — Depreciation: 500616000.00
CELLO.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 503254000.00
CELLO.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 503254000.00
CELLO.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 500616000.00
CELLO.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 212231034.00
CELLO.NS income_statement (annual, 2023-03-31) — Diluted EPS: 12.54
CELLO.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 2661273000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Dividends Payable: 5469000.00
CELLO.NS cash_flow (annual, 2023-03-31) — Dividends Received Cfi: 6140000.00
CELLO.NS income_statement (annual, 2023-03-31) — EBIT: 3869409000.00
CELLO.NS income_statement (annual, 2023-03-31) — EBITDA: 4372663000.00
CELLO.NS cash_flow (annual, 2023-03-31) — End Cash Position: 306167000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 53783000.00
CELLO.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: 3238200000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 2588142000.00
CELLO.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: 1130962000.00
CELLO.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: 21160000.00
CELLO.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of Business: -3364000.00
CELLO.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: -1601000.00
CELLO.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 225127000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 51854000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 4685554000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 4997910000.00
CELLO.NS income_statement (annual, 2023-03-31) — Gross Profit: 8395174000.00
CELLO.NS income_statement (annual, 2023-03-31) — Interest Expense: 17560000.00
CELLO.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 17560000.00
CELLO.NS income_statement (annual, 2023-03-31) — Interest Income: 69734000.00
CELLO.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 69734000.00
CELLO.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: 0.00
CELLO.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 0.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Inventory: 4297599000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 6625153000.00
CELLO.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -5568222000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 509968000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Investmentsin Associatesat Cost: 7886000.00
CELLO.NS cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 4750000000.00
CELLO.NS cash_flow (annual, 2023-03-31) — Issuance Of Debt: 1537000000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 190788000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 71351000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 86616000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 157967000.00
CELLO.NS cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 0.00
CELLO.NS cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -2805771000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Long Term Equity Investment: 7886000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 2264552000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Minority Interest: 1999396000.00
CELLO.NS income_statement (annual, 2023-03-31) — Minority Interests: -189235000.00
CELLO.NS cash_flow (annual, 2023-03-31) — Net Business Purchase And Sale: -4144343000.00
CELLO.NS cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: -151189000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Net Debt: 2954491000.00
CELLO.NS cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: 0.00
CELLO.NS income_statement (annual, 2023-03-31) — Net Income: 2661273000.00
CELLO.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 2661273000.00
CELLO.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 2850508000.00
CELLO.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 2661273000.00
CELLO.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 2661273000.00
CELLO.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 3851849000.00
CELLO.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 2850508000.00
CELLO.NS cash_flow (annual, 2023-03-31) — Net Intangibles Purchase And Sale: -21551000.00
CELLO.NS income_statement (annual, 2023-03-31) — Net Interest Income: 52174000.00
CELLO.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: -332816000.00
CELLO.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: -1268771000.00
CELLO.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: -2805771000.00
CELLO.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: 52174000.00
CELLO.NS cash_flow (annual, 2023-03-31) — Net Other Financing Charges: 32081000.00
CELLO.NS cash_flow (annual, 2023-03-31) — Net Other Investing Changes: -30000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Net PPE: 3319651000.00
CELLO.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -1010652000.00
CELLO.NS cash_flow (annual, 2023-03-31) — Net Preferred Stock Issuance: 4750000000.00
CELLO.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: 1537000000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 3312641000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 47190000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 84057000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 25013000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 82670000.00
CELLO.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 4459996000.00
CELLO.NS income_statement (annual, 2023-03-31) — Normalized Income: 2725902588.33
CELLO.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 2273498000.00
CELLO.NS income_statement (annual, 2023-03-31) — Operating Income: 3860386000.00
CELLO.NS income_statement (annual, 2023-03-31) — Operating Revenue: 17864814000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 212231034.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 241005000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 51854000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Other Inventories: 188352000.00
CELLO.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: -15030000.00
CELLO.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 485000.00
CELLO.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 1007427000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Other Payable: 56303000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Other Properties: 1225771000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 54765000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 1316126000.00
CELLO.NS income_statement (annual, 2023-03-31) — Other Special Charges: -10398000.00
CELLO.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Payables: 1438960000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Preferred Securities Outside Stock Equity: 4831000000.00
CELLO.NS cash_flow (annual, 2023-03-31) — Preferred Stock Issuance: 4750000000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 499324000.00
CELLO.NS income_statement (annual, 2023-03-31) — Pretax Income: 3851849000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
CELLO.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: 6780000.00
CELLO.NS cash_flow (annual, 2023-03-31) — Purchase Of Business: -4145843000.00
CELLO.NS cash_flow (annual, 2023-03-31) — Purchase Of Intangibles: -21551000.00
CELLO.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment: -395943000.00
CELLO.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -1120985000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 1103482000.00
CELLO.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 9469640000.00
CELLO.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 503254000.00
CELLO.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 211562000.00
CELLO.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 211562000.00
CELLO.NS cash_flow (annual, 2023-03-31) — Repayment Of Debt: -2805771000.00
CELLO.NS cash_flow (annual, 2023-03-31) — Repurchase Of Capital Stock: -151189000.00
CELLO.NS income_statement (annual, 2023-03-31) — Research And Development: 10199000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 147370000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 5541482000.00
CELLO.NS cash_flow (annual, 2023-03-31) — Sale Of Business: 1500000.00
CELLO.NS cash_flow (annual, 2023-03-31) — Sale Of Investment: 63127000.00
CELLO.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 110333000.00
CELLO.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 1106710000.00
CELLO.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 1331837000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Share Issued: 212231034.00
CELLO.NS cash_flow (annual, 2023-03-31) — Short Term Debt Issuance: 1537000000.00
CELLO.NS cash_flow (annual, 2023-03-31) — Short Term Debt Payments: -2795430000.00
CELLO.NS income_statement (annual, 2023-03-31) — Special Income Charges: -60033000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 3364495000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 3312641000.00
CELLO.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: -22703411.67
CELLO.NS income_statement (annual, 2023-03-31) — Tax Provision: 1001341000.00
CELLO.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.26
CELLO.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -1010364000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Total Assets: 15516939000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 3451111000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Total Debt: 3351069000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 5363891000.00
CELLO.NS income_statement (annual, 2023-03-31) — Total Expenses: 14004428000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 10153048000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 4118117000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 5098040000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 35516000.00
CELLO.NS income_statement (annual, 2023-03-31) — Total Unusual Items: -87333000.00
CELLO.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: -87333000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Work In Process: 417623000.00
CELLO.NS balance_sheet (annual, 2023-03-31) — Working Capital: 6343814000.00
CELLO.NS income_statement (annual, 2023-03-31) — Write Off: 70431000.00
CELLO.NS income_statement (annual, 2024-03-31) — +Operating Expense: 5988808000.00
CELLO.NS income_statement (annual, 2024-03-31) — +Total Revenue: 20002641000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 1441856000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 6105834000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -2214701000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 4725960000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -54557000.00
CELLO.NS income_statement (annual, 2024-03-31) — Amortization: 18798000.00
CELLO.NS cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 18798000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Assets Held For Sale Current: 0.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 578395000.00
CELLO.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 212219615.00
CELLO.NS income_statement (annual, 2024-03-31) — Basic EPS: 15.60
CELLO.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 306167000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 720976000.00
CELLO.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -2640084000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 79695000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 1061155000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 321780000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 1475077000.00
CELLO.NS cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -46377000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 321780000.00
CELLO.NS cash_flow (annual, 2024-03-31) — Change In Inventory: -323936000.00
CELLO.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: -3586000.00
CELLO.NS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: 39155000.00
CELLO.NS cash_flow (annual, 2024-03-31) — Change In Payable: 90202000.00
CELLO.NS cash_flow (annual, 2024-03-31) — Change In Receivables: -1480788000.00
CELLO.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: -1666900000.00
CELLO.NS cash_flow (annual, 2024-03-31) — Changes In Cash: 15613000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Common Stock: 1061155000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 11492176000.00
CELLO.NS cash_flow (annual, 2024-03-31) — Common Stock Issuance: 0.00
CELLO.NS cash_flow (annual, 2024-03-31) — Common Stock Payments: 0.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 2082103000.00
CELLO.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 9484238000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Current Assets: 13231764000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 23673000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Current Debt: 3350050000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 3373723000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 5534640000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 15859000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Defined Pension Benefit: 132000.00
CELLO.NS cash_flow (annual, 2024-03-31) — Depreciation: 567460000.00
CELLO.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 567460000.00
CELLO.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 567460000.00
CELLO.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 548662000.00
CELLO.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 212219615.00
CELLO.NS income_statement (annual, 2024-03-31) — Diluted EPS: 15.60
CELLO.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 3310626000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Dividends Payable: 5084000.00
CELLO.NS cash_flow (annual, 2024-03-31) — Dividends Received Cfi: 0.00
CELLO.NS income_statement (annual, 2024-03-31) — EBIT: 4775554000.00
CELLO.NS income_statement (annual, 2024-03-31) — EBITDA: 5343014000.00
CELLO.NS cash_flow (annual, 2024-03-31) — End Cash Position: 321780000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 58369000.00
CELLO.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: 260080000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 2485795000.00
CELLO.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: -328271000.00
CELLO.NS cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: -101942000.00
CELLO.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of Business: 0.00
CELLO.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: -37750000.00
CELLO.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 156482000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 24280000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 6160391000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 7891640000.00
CELLO.NS income_statement (annual, 2024-03-31) — Gross Profit: 10518403000.00
CELLO.NS income_statement (annual, 2024-03-31) — Interest Expense: 25533000.00
CELLO.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 25533000.00
CELLO.NS income_statement (annual, 2024-03-31) — Interest Income: 72050000.00
CELLO.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 72050000.00
CELLO.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -22289000.00
CELLO.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 64705000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Inventory: 4621535000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 15119602000.00
CELLO.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -2556280000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 636764000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Investmentsin Associatesat Cost: 3171000.00
CELLO.NS cash_flow (annual, 2024-03-31) — Issuance Of Capital Stock: 0.00
CELLO.NS cash_flow (annual, 2024-03-31) — Issuance Of Debt: 1077663000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 220641000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 56022000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Long Term Debt: 277376000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 333398000.00
CELLO.NS cash_flow (annual, 2024-03-31) — Long Term Debt Issuance: 1077663000.00
CELLO.NS cash_flow (annual, 2024-03-31) — Long Term Debt Payments: -699495000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Long Term Equity Investment: 3171000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 25282000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 3277086000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Minority Interest: 2206435000.00
CELLO.NS income_statement (annual, 2024-03-31) — Minority Interests: -251210000.00
CELLO.NS cash_flow (annual, 2024-03-31) — Net Business Purchase And Sale: 0.00
CELLO.NS cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: 0.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Net Debt: 3305646000.00
CELLO.NS cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: -32973000.00
CELLO.NS income_statement (annual, 2024-03-31) — Net Income: 3310626000.00
CELLO.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 3310626000.00
CELLO.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 3561836000.00
CELLO.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 3310626000.00
CELLO.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 3310626000.00
CELLO.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 4750022000.00
CELLO.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 3561836000.00
CELLO.NS cash_flow (annual, 2024-03-31) — Net Intangibles Purchase And Sale: 0.00
CELLO.NS income_statement (annual, 2024-03-31) — Net Interest Income: -25533000.00
CELLO.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: -92925000.00
CELLO.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: 378168000.00
CELLO.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: 378168000.00
CELLO.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -25533000.00
CELLO.NS cash_flow (annual, 2024-03-31) — Net Other Financing Charges: -19745000.00
CELLO.NS cash_flow (annual, 2024-03-31) — Net Other Investing Changes: -2000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Net PPE: 5676939000.00
CELLO.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -2528060000.00
CELLO.NS cash_flow (annual, 2024-03-31) — Net Preferred Stock Issuance: 0.00
CELLO.NS cash_flow (annual, 2024-03-31) — Net Short Term Debt Issuance: 671345000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 11467896000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Assets: 20766000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 125905000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 25282000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 42161000.00
CELLO.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 5343014000.00
CELLO.NS income_statement (annual, 2024-03-31) — Normalized Income: 3310626000.00
CELLO.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 2311813000.00
CELLO.NS income_statement (annual, 2024-03-31) — Operating Income: 4529595000.00
CELLO.NS income_statement (annual, 2024-03-31) — Operating Revenue: 20002641000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 212231034.00
CELLO.NS cash_flow (annual, 2024-03-31) — Other Cash Adjustment Outside Changein Cash: 1000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 604769000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 247919000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 1000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 24280000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Other Inventories: 216113000.00
CELLO.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: -50290000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 287029000.00
CELLO.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 250674000.00
CELLO.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 3526731000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Other Payable: 304179000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Other Properties: 1590834000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 49382000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 1153297000.00
CELLO.NS income_statement (annual, 2024-03-31) — Other Special Charges: -37750000.00
CELLO.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Payables: 1783577000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Preferred Securities Outside Stock Equity: 0.00
CELLO.NS cash_flow (annual, 2024-03-31) — Preferred Stock Issuance: 0.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 661569000.00
CELLO.NS income_statement (annual, 2024-03-31) — Pretax Income: 4750021000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
CELLO.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: 17024000.00
CELLO.NS cash_flow (annual, 2024-03-31) — Purchase Of Business: 0.00
CELLO.NS cash_flow (annual, 2024-03-31) — Purchase Of Intangibles: 0.00
CELLO.NS cash_flow (annual, 2024-03-31) — Purchase Of Investment: -2471552000.00
CELLO.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -2640084000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 1333158000.00
CELLO.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 9484238000.00
CELLO.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 567460000.00
CELLO.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 248182000.00
CELLO.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 248182000.00
CELLO.NS cash_flow (annual, 2024-03-31) — Repayment Of Debt: -699495000.00
CELLO.NS cash_flow (annual, 2024-03-31) — Repurchase Of Capital Stock: 0.00
CELLO.NS income_statement (annual, 2024-03-31) — Research And Development: 5935000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 318367000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 8852107000.00
CELLO.NS cash_flow (annual, 2024-03-31) — Sale Of Business: 0.00
CELLO.NS cash_flow (annual, 2024-03-31) — Sale Of Intangibles: 8776000.00
CELLO.NS cash_flow (annual, 2024-03-31) — Sale Of Investment: 2378627000.00
CELLO.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 112024000.00
CELLO.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 1546819000.00
CELLO.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 1703301000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Share Issued: 212231034.00
CELLO.NS cash_flow (annual, 2024-03-31) — Short Term Debt Issuance: 671345000.00
CELLO.NS cash_flow (annual, 2024-03-31) — Short Term Debt Payments: -484100000.00
CELLO.NS income_statement (annual, 2024-03-31) — Special Income Charges: 15972000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 11492176000.00
CELLO.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 11467896000.00
CELLO.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 0.00